HLM Leads $16M Growth Investment in HPS/PayMedix; $33M Financing Raised
January 13, 2026
HPS/PayMedix closed $33 million of equity and debt financing to accelerate national growth of its healthcare financing and payments platform. The round was led by HLM Investment Partners ($16M growth equity) and included Escalate Capital Partners (providing a $17M term debt facility), RVM Enterprises, and existing investor SV Health Investors.
- Buyers
- HLM Investment Partners, Escalate Capital Partners, RVM Enterprises, SV Health Investors
- Targets
- HPS/PayMedix
- Industry
- Healthcare Services
- Location
- Wisconsin, United States
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.